Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056132 · ClinicalTrials.gov registry record
Breath Condensate Study in Patients With Cystic Fibrosis.
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 50
- Enrollment target
NCT02056132: Completed study, sponsored by University of Florida.
NCT02056132 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02056132 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
There is an urgent need for a noninvasive method to diagnose bronchial infections and exacerbations in patients with Cystic Fibrosis (CF). The current method to diagnosed infections involves either collecting a sputum sample or obtaining a bronchoalveolar lavage (BAL). However, some patients cannot produce sputum. At the same time the decision of when a patient has an exacerbation continues to be very subjective. In this exploratory study, we propose a new, noninvasive method to diagnose bronchial infections and to evaluate possible markers of inflammation that can assist in a noninvasive way in the determination of exacerbations.
Interventions
- OTHER Exhaled Breath Condensate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-02 |
| Est. Completion | 2023-08-22 |
What the finished NCT02056132 record still lists
NCT02056132 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Exhaled Breath Condensate is the first listed.
NCT02056132 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02056132 about?
NCT02056132 is a clinical study titled "Breath Condensate Study in Patients With Cystic Fibrosis.". There is an urgent need for a noninvasive method to diagnose bronchial infections and exacerbations in patients with Cystic Fibrosis (CF). The current method to diagnosed infections involves either collecting a sputum sample or obtaining a bronchoalveolar lavage (BAL). However, some patients cannot ...
What is the current status of trial NCT02056132?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-02. Estimated completion is 2023-08-22.
What interventions are being tested in trial NCT02056132?
The interventions under investigation include: Exhaled Breath Condensate (OTHER).
Who is sponsoring clinical trial NCT02056132?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia